Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Organizational structures of dialysis access care and the role of interventional nephrology: a Germany-wide survey.

BMC nephrology·2026

Same author

LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16.

Pathogens (Basel, Switzerland)·2025

Same author

Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data.

Kidney international reports·2025

Same author

Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC.

NPJ genomic medicine·2025

Same author

Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for Psychosis.

Schizophrenia (Heidelberg, Germany)·2025

Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012

Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012

Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012

Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012

Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012

Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012

See all related articles

Search research articles

Related Experiment Video

Updated: May 23, 2026

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

Curing diabetes with transplantation?

Anja Richter¹, Susan M Lerner, Bernd Schröppel

¹Nephrology Division, Mount Sinai School of Medicine, New York, NY, USA.

The Mount Sinai Journal of Medicine, New York

|April 14, 2012

Summary

This summary is machine-generated.

Type 1 diabetes impacts over a million Americans, with current insulin therapies failing to prevent serious long-term complications. Beta-cell replacement through transplantation offers a path to insulin independence and improved health outcomes.

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Related Experiment Videos

Last Updated: May 23, 2026

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Area of Science:

Endocrinology
Transplantation Medicine
Metabolic Diseases

Background:

Type 1 diabetes affects over 1 million people in the US, representing up to 10% of all diabetes cases.
Current glycemic control with exogenous insulin is often incomplete, leading to severe long-term complications like retinopathy, neuropathy, vasculopathy, and nephropathy.

Purpose of the Study:

To explore beta-cell replacement via whole-pancreas or islet transplantation as a strategy for achieving long-term insulin independence in Type 1 diabetes patients.

Main Methods:

This study reviews the potential of whole-pancreas transplantation and islet transplantation.
Focuses on the physiological regulation achievable through these advanced therapeutic approaches.

Main Results:

Beta-cell replacement aims to achieve long-term insulin independence.
Potential benefits include improved quality of life, prevention of recurrent diabetic nephropathy, stabilization of secondary complications, and enhanced survival rates.

Conclusions:

Beta-cell replacement therapy represents a significant advancement over conventional insulin delivery methods.
Transplantation offers a superior level of physiological regulation for Type 1 diabetes management.